血清心血管蛋白-1作为内动脉瘤的一个新生物标志物
Weidong Men1, Xuehao Zhang1, Lijian Zhang1
1Department of Neurosurgery, Affiliated Hospital of Hebei University, Hebei University, Baoding, 071000, Hebei Province, China.
心脏增生蛋白-1 (CT-1) 作为检测内动脉瘤 (IA) 和评估破裂风险的非侵入性生物标志物具有前景. 患者中CT-1水平升高表明其对早期查的临床实用性.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 血管医学 血管医学
背景情况:
- 内动脉瘤 (IAs) 具有显著的破裂风险,可能导致下关节出血.
- 目前对IA的诊断方法具有侵入性和成本,需要寻找非侵入性替代品.
研究的目的:
- 为了评估血清炎症标志物和心脏增生蛋白-1 (CT-1) 作为潜在的AI存在的非侵入性生物标志物.
- 评估这些标记在分层IA破裂风险中的有用性.
主要方法:
- 用ELISA测量了IL-6,IL-10,IL-33,S100B,E-selectin和CT-1的血清水平在131名IA患者和21名控制人群中.
- 统计分析包括克鲁斯卡尔-瓦利斯测试,ROC曲线分析和物流回归来确定风险因素.
主要成果:
- 与对照组相比,IA患者的血清CT-1水平明显高于IA患者 (p = 0.0002),在破裂的IA中观察到的最高水平.
- CT-1显示IA (AUC=0.7801) 和破裂IA (AUC=0.7911) 的诊断潜力.
- 其他测试的标记物 (IL-6,IL-10,IL-33,S100B,E-selectin) 没有显著差异. 老年和吸烟被确定为重要的IA风险因素.
结论:
- 心脏otrophin-1 (CT-1) 是一个有前途的血清生物标志物用于检测内动脉瘤.
- 升高的CT-1水平,特别是在破裂的情况下,表明其潜在的非侵入性风险分层.
- 建议在更大的患者队伍中进行进一步验证,以确认临床效用.
更多相关视频
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
